Background: Studies have shown that medical devices comprising strontium contribute to bone healing and osseointegration. The aim of this study was to evaluate the in vivo performance of surface-functionalized implants (Ti-Sr-O) showing predictable release characteristics of strontium and compare it to performance a commercially available fluoride-modified surface.
INTRODUCTION
Artificial root insertion is a clinically well-established treatment method, with observations in defined study groups revealing satisfying and predictable results for implant success in the long term. 1 However, with a growing number of elderly patients in need of implant treatment, different challenges remain in modern dentistry, 2 e.g., diminished hard and soft tissue conditions frequently encountered because of antiresorptive therapy or radiation oncology. Additionally, an increase in peri-implantitis caused by both patient-and implant-related factors has been observed for various treatment options. 3 Patient risk factors could potentially be minimized by, among others, optimizing oral hygiene, smoking behavior instruction, and treatment of periodontal disease. 3 From the industrial and scientific side, surface functionalization of dental implants draws the attention of modern implantology, as underlined by an extensive number of investigations performed on surface modifications during the past decades. [4] [5] [6] [7] [8] [9] Research performed during the last decade was focused on acceleration of osseointegration by surface adjustment procedures diversifying physical and chemical properties, as well as by macro-and microtopography. 9 Specific implant geometries were established 10 at an early point as one of the keys to success with respect to obtaining adequate bone healing and subsequent stability for loading. Further investigations reported on significant enhancement of osseointegration after sandblasting and acid etching, 11 laser ablation, 12 anodic oxidation 13 utilizing a protective nitrogen atmosphere during rinsing, 14 or incorporation of fluoride ions (F − -modified). 15 The latter approach, with implementation of fluoride anions, yields osteoinduction at the implant interface. Its impact on bone metabolism seems to be mediated on several levels, with an increase in bone density via phosphorylation of mitogen-activated protein kinase and activation of cellular protein tyrosine kinases, ultimately leading to osteogenic cell proliferation. 16 Moreover, fluoride-modified titanium surfaces promote bone mineralization and enhance bone formation, with observations of beneficial effects even for compromised cell lines, e.g., early adhesion of irradiated osteoblasts. 17, 18 In vivo investigations reported on enhanced bone parameters 6, 19, 20 and clinical observations found superior results for fluoride-modified implant surfaces, [21] [22] [23] with subsequent assertion as established surface modification, routinely used in daily clinical practice.
The alkali earth metal strontium (Sr), another trace element in the human body, affects bone metabolism through a variety of mechanisms. In vitro studies showed that strontium ranelate (SrRan) affects deployment of mesenchymal stem cells (MSCs) 24, 25 by blocking their differentiation into adipocytes 26 via upregulation of osteogenic markers such as Runx2, bone sialoprotein, and osteocalcin. 27 Additionally, receptor activator of nuclear factor-kappa B (RANK)/RANK ligand (RANKL)/osteoprogerin (OPG), as one of the major bone metabolism pathways, is also affected by strontium. 28 Clinical studies have demonstrated that SrRan can increase bone mineral density in postmenopausal women, 29 with subsequent reports of risk reduction in relation to vertebral fractures of up to 49% following oral administration of SrRan. 30 Based on this knowledge, animal investigations reported on enhancement of osseointegration via both oral administration of SrRan and strontiumbased surface modifications. 31, 32 With respect to controlled liberation from strontium-functionalized titanium surfaces, magnetron sputtering was used to provide a nanostructured Ti-Sr-O thin film coating with sustained release of strontium. [33] [34] [35] The aim of the current investigation was to assess osseointegration rates of a magnetron sputtered functionalized surface with tailored release of strontium and compare it to a fluoride-modified, commercially available implant.
MATERIALS AND METHODS

Sample preparation and characterization
Surface preparation and characterization were investigated in detail earlier for both fluoride-modified surface 36 and TiSr-O coating (including release kinetics). 33, 34 In brief, test implants, measuring 8 mm in length and with a maximum outer diameter of 3.75 mm, were manufactured from Grade 4 titanium. * The implants had a turned surface finish. One portion of the manufactured items were retained to be used as reference implants and the Ti-Sr-O coating was applied to the other portion, using an industrial scale magnetron sputtering platform. Subsequently, surface morphology and coating thickness were evaluated for the Ti-Sr-O group, using scanning electron microscopy (SEM). † To allow for measuring the coating thickness, Ti-Sr-O coated implants were embedded in a conducting resin ‡ and subsequently processed to allow for obtaining a cross-sectional view of the coating. In short, the sample processing was performed by initial grinding, using a grit size of 220. Subsequently, surface polishing was performed in three steps, initially using a suspension of abrasive particles of 9 m in size, then 3 m and, finally, 1 m. § The thickness was measured at various positions, using the measuring tool of the SEM software. The fluoride-modified implant system ¶ (implant diameter 3.5 mm, length 8 mm) was acquired through standard commercial trade routes.
Atomic absorption spectrometry (AAS)
Serum levels of strontium and calcium were assessed after withdrawing blood samples of approximately 1.5 mL through the marginal ear vein preoperatively and on days 1, 3, 5, 7, and 14 after surgery. The procedure was performed according to the recommendation of Die Gesellschaft für Versuchstierkunde/Society of Laboratory Animal Science. 37 Strontium was analyzed using an atomic absorption spectrometer, equipped with a graphite furnace GF95Z at 460.7 nm # with background correction. Calcium was determined using flame atomic absorption spectrometer in a nitrous oxide-acetylene (4.5 L/min) flame at 422.7 nm. # The accuracy of the strontium and calcium measurements was assessed through the analysis of control samples. ‖ The interassay coefficient of variance (CV) was ˂ 5.5% and the intraassay CV ˂ 2%. 
Surgery
Surgery was performed with permission of the Austrian government (BMWF-66.011/0143-II/3b/2013) and the ethics committee of the Medical University Innsbruck in concordance with the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines. 38 After a two-week settling period, twelve 9-month-old, male New Zealand white rabbits underwent surgical procedure under aseptic conditions, with insertion of either a Ti-Sr-O (diameter: 3.75 mm, length: 8 mm), fluoride-modified (diameter: 3.5 mm, length: 8 mm), or Grade 4 titanium (diameter: 3.75 mm, length: 8 mm) implant. Animals were randomly chosen and both femoral condyles used as implantation sites, resulting in rabbits carrying either Ti-Sr-O/F − -modified, or Ti-Sr-O/Ti, or F − -modified/Ti per animal; hence, no animal was bearing the same group twice. Surgical procedure was performed after anesthetizing the animals with medetomidine * (50 g/kg) and ketamine † (5 mg/kg) intravenously. Under sterile conditions, insertion sites were prepared according to manufacturer protocols in the distal femoral condyle ( Figure 1 ). All drilling procedures were performed while cooling the operation site with isotonic saline solution. ‡ Wound closure was conducted with absorbable glycolide/L-lactide sutures, § with submerged healing for 2 weeks for all implants. Animals received both analgesic and antibiotic medication subcutaneously with carprofen ¶ (4 mg/kg) and enrofloxacin (7.5 mg/kg). # Rabbits were held with a 12-hour:12-hour light:dark cycle and a room temperature of 18 • C-20 • C, with humidity of 45%-65%. Individual housing was provided in cages (68 × 69 × 66 cm), with an additional raised area (76 × 29 cm). The * Orion Corporation, Espoo, Finland † Ketavet ® , Zoetis GmbH, Zurich, Switzerland ‡ Sigma-Aldrich, Schnelldorf, Germany § Vicryl 4-0, Ethicon, Johnson & Johnson Medical GmbH Norderstedt, Germany ¶ Rimadyl ® , Zoetis GmbH, Zurich, Switzerland # Baytril ® , Bayer AG, Leverkusen, Germany animals were fed with rabbit pellets ‖ ad libitum and tap water was available by an automatic drinking system, also ad libitum.
Two weeks following surgery, animals were sacrificed with pentobarbital * * (400 mg/kg), with subsequent harvesting of peri-implant tissue. Samples were fixated in paraformaldehyde, dehydrated with ascending grades of alcohol, cleared with xylene, infiltrated, and finally embedded in methyl methacrylate (MMA), † † with subsequent non-decalcified histological sectioning.
Histologic evaluation
After removal of the soft tissue, polyether ether ketone guide pins were inserted into the internal geometry of the implant, for visualization of the implant axis, prior to the embedding process. Specimens were applied to MMA for 2 weeks, according to manufacturer instructions. Subsequently, the resulting MMA blocks were glued onto microscope slides and cut in half along the implant axis. Sectioning was conducted as described by Donath and Breuner, 39 with application of a second microscope slide onto the prior sanded and polished surface. The so-called sandwich block was cut with a diamond-covered saw blade and subsequently ground with abrasive paper to a sample thickness of approximately 50 m, as previously described. 33, 35 Slides were subjected to final polishing ‡ ‡ and staining with toluidine blue. Image acquisition was conducted with a binocular light microscope § § and associated software with evaluation of new bone formation (BF%) and bone-to-implant contact (BIC%) within defined areas at 40 × magnification. Two slides per group were investigated, with analysis of both sides of the inserted implant in the cancellous part of the femur. Direct BIC as 
Statistical analysis
Analysis was performed using commercially available software programs. * † The data for serum concentration, BIC%, and BF% are presented as mean ± standard deviation. The data were plotted in box plots and inspected for outliers. The normal distribution of the data was assessed by Shapiro-Wilk test for each group. Levene test was used for assessment of * M SPSS Statistics 24, IBM, Armonk, NY † R 3.3.1, R Foundation for statistical computing, Vienna, Austria homogeneity of variances for all groups. To explore if there were statistical differences between the study groups, a oneway analysis of variance was performed together with GamesHowell post hoc analysis, because our data did not meet the assumption of homogeneity of variances. The significance level for statistical tests was set at = 0.05.
RESULTS
All animals completed the study as planed within the predetermined 2-week observation period, assuring n = 8 for all investigated groups. Anticipated swelling in the knee joint area was observed in all the animals, up to 7 days postoperatively, with no complications such as wound dehiscence, infection, allergic reaction, premature exposure, or implant loss. Blood sampling was completed without any lasting discomfort. 
Sample preparation and characterization
SEM was utilized to evaluate the morphology of the Ti-Sr-O coating applied to the turned implant surface. As is evident from the images, a nanometer-sized, porous, cauliflower-like structure is observed. Figure 3 and Figure 4 illustrate representative top-and cross-sectional views of an implant carrying the Ti-Sr-O coating.
Atomic absorption spectrometry
Strontium serum concentrations of about 100 g/L were measured at the beginning of the observation period, which decreased over time to a concentration of approximately 60 g/L at 14 days after implantation. No statistically significant differences in strontium serum levels were found between animals hosting Ti-Sr-O functionalized implants and rabbits
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Concentrations of strontium and calcium in serum of rabbits were measured with GF-AAS before (0) and 1 to 14 days after the surgical procedure. Data are presented as mean ± standard deviation carrying uncoated surfaces (P > 0.05). Additionally, serum analysis revealed constant levels of calcium ranging from 2.5 to 3.5 mmol/L throughout the observation period of 14 days, without statistically significant differences between Ti-Sr-O and the uncoated surfaces ( Figure 5 ).
Histological evaluation
Histomorphometric analysis is shown in Figure 2 , with exemplary histologic slides of the investigated groups and associated reference boxes used for evaluation. Ti-Sr-O showed a higher mean BIC% compared to the fluoride-modified surface, however, the difference was not statistically significant. As expected, the turned Ti Grade 4 surface revealed values inferior to both investigated surfaces, as seen in Figure 6 ; the difference was statistically significant (P < 0.001). Histomorphometry of BF% is also presented in Figure 6 . Analysis in ROI-I (0-250 m) revealed significantly more bone apposition for Ti-Sr-O compared to the fluoride-modified surface (P < 0.05) and Ti (P < 0.01). This was also observed for bone apposition in ROI-II (250-500 m). Additionally, Ti showed inferior values to the fluoride-modified surface in ROI-II.
DISCUSSION
Despite satisfying results in various study groups, 1,40 dental implantology is facing multiple challenges due to demographic changes and medical treatments interfering with bone metabolism, e.g., irradiation or antiresorptive therapy, 41, 42 with potential risk of implant failure. Therefore, research focused on possible surface modifications, with surface functionalization in particular, aiming for enhanced osteogenic response altering the biological process of bone anchorage, resulting in various dental implant surfaces used nowadays. 9 F I G U R E 6 BIC% and BF% in regions of interest I and II (ROI-I and II) 2 weeks after surgery. Significant differences of Ti in relation to BIC% of Ti-Sr-O and F − -modified are marked with ‡ (P < 0.001). Significant differences with respect to BF% of Ti-Sr-O compared to F − -modified and Ti are marked with * (P < 0.05), † (P < 0.01), and ‡ (P < 0.001), respectively. Data are presented as mean ± standard deviation By extension, the aim of this study was to evaluate the impact of strontium-functionalized titanium manufactured via physical vapor deposition compared to a commercially available fluoride-modified surface, with respect to BIC and BF in a rabbit femur model in early osseointegration stages. Basic research exposed fluoride as bone anabolic agent, with increment of bone density and osteoblastic cell proliferation. 16 Both in vitro and in vivo studies demonstrated enhanced osteoblastic differentiation, with interfacial bone formation being responsible for improved osseointegration patterns. 17, 43 Several authors reported improved bone healing with increased BIC and a so-called stronger BIC interface. 17, 19, 44 Based on this research, surface modification of titanium with incorporation of fluoride evolved as a commonly used concept in dental implantology, 9,23 with predictable overall outcome of fluoride-modified dental implants.
Strontium as osteoinductive agent 45, 46 has been shown to play a role in bone metabolism and was investigated initially as therapeutic option in osteoporosis treatment. Since the first report on strengthening bone mineral density in the 1950s, 47 numerous experimental 45 and preclinical studies 31, 33 have reported beneficial effects of strontium on bone metabolism. Fundamental research reported on MSC differentiation toward osteogenic lineage and interference in RANK/RANKL/OPG pathway and Wnt signaling, 45 while in vivo experiments observed escalating results for BIC and bone apposition. 31, 33 With respect to dental implantology, liberated strontium from functionalized surfaces could further promote early bone apposition and thereby enhance osseointegration. We took advantage of strontium's effects on bone growth and functionalized titanium implants with a thin Ti-Sr-O coating synthesized by means of magnetron sputtering, resulting in sustained liberation of strontium. 34 Yet it remained unclear whether there is a risk for systemic effects from the released strontium. Thus, the prior identified release from the surface in vitro 33, 34 was followed up by utilizing atomic absorption spectrometry to determine the in vivo strontium blood serum concentration. The rationale behind this approach was that an increase in strontium blood serum concentration would indicate a potential risk for systemic effects. By monitoring which animals were carrying Ti-Sr-O implants and which were not, it was possible to do a split-group comparison of the strontium blood serum concentrations. The collected data do not suggest any risk for systemic interference resulting from the strontium released from the implant surface, as no significant differences were found for the investigated groups.
Insertion of implants into the femoral condyle of New Zealand white rabbits represents a common model for osseointegration research within the field of dental implantology, [48] [49] [50] mimicking submerged and unloaded healing conditions. Histomorphometric analysis of bone anchorage parameters revealed similar results, with slight advantages for Ti-Sr-O when looking at BIC%. As listed in numerous publications over the years, BIC% is regarded as the gold standard for evaluation of osseointegration. Similar BIC% values for Ti-Sr-O and fluoride-modified implants proved adequate osteogenic response to both surfaces with different topographic and chemical features. Additionally, statistically significant differences with respect to BF% within 250 m (ROI-I) and 500 m (ROI-II) from the implant interface were observed. These results were interpreted as a consequence of the sustained release of strontium from the functionalized interface in the near-surface environment. The aforementioned increase in new bone formation up to 500 m distant could increase implant fixation and should be further investigated. Nonetheless, a potential enhancement of mechanical anchorage should be interpreted cautiously because no biomechanical or stability evaluation such as removal torque testing or resonance frequency analysis was applied. In order to carefully plan the current study and minimize the number of animals, we performed statistical power calculations in accord with replacement, reduction, and refinement principles for in vivo animal research before starting our experiments. This possible shortcoming with respect to the number of analyzed implants should be accentuated: results must be interpreted with caution, as small sample sizes could potentially impact the validity of the outcome. However, although the sample size was large enough to answer our questions, the results still need further replication and confirmation. Hence, the presented study could be interpreted as preclinical pilot study.
The results are notable, as the experimental group represented a machined smooth surface functionalized with Ti-Sr-O coating compared to a moderately rough fluoride-modified surface. Even though it was not the focus of our investigation, this fact emphasizes the positive osteoinductive effect of strontium.
To our knowledge, this is the first time an implant with a turned surface finish has been found to outperform a state-of-the-art dental implant surface with respect to bone apposition in defined regions of interest. Histomorphometric results showed that strontium-modified titanium implants can achieve commensurable bone healing parameters, presumably due to controlled release of strontium in comparison to the routinely used fluoride-modified surface. Controllable amounts of strontium released from the surface in combination with a nanotopography, makes this modification a potential candidate for altering the biological response of osteogenic cells towards accelerated bone growth and thereby enhancing osseointegration.
CONCLUSION
This is the first in vivo investigation of biofunctionalized titanium implants, with tailored release of strontium, compared to a fluoride-modified dental surface. Increased bone apposition with improved bone anchorage parameters in virtue of local near-surface effects of strontium was evident. The controlled release of the osteogenic element strontium from implants functionalized with a magnetron sputtered Ti-Sr-O coating improved osseointegration parameters and could thus serve as a possible surface modification in medical implantology.
